A government-controlled pharmaceutical program offering a range of 'mood stabilizers' based on AI-analyzed mental health profiles. Access is strictly regulated and tied to social credit scores, prioritizing citizens deemed 'emotionally stable' and 'productive' for societal benefit. Creates a black market for authentic, unregulated mental health treatments.